Chennai, July 15
Sanction has been accorded to a trial by the Indian Council of Medical Research’s Tuberculosis institute right here to review the efficacy of BCG vaccine within the aged within the combat in opposition to COVID-19, the federal government mentioned on Wednesday.
Chief Minister Okay Palaniswami, in an order, has given the state’s approval after the ICMR sought Tamil Nadu authorities’s permission to review the efficacy of the Bacillus Calmette- Gurin (BCG) vaccine in senior residents at its National Institute for Research in Tuberculosis (NIRT) at Chetpet right here,Health Minister C Vijayabaskar mentioned.
“The ICMR’s tuberculosis institute is set to begin the trial very soon,” he mentioned in a press release.
He hoped that vaccinating the aged with the time-tested BCG would assist scale back the depth of COVID-19, admissions at hospitals and mortality charges.
Describing the state’s approval by Palaniswami for a trial right here as amongst measures to guard individuals’s welfare throughout the ongoing combat in opposition to COVID-19, Vijayabaskar mentioned anti-viral measures would additional be stepped up.
The NIRT underneath the ICMR is an internationally recognised establishment for TB analysis. PTI